| Position | Action |
|---|---|
| Unfavorable entry with cooling momentum and recovery priced in | Trim ~30% of position |
| Confirmed support test at $58.20 with MACD expansion | Re-enter/re-add at $58.20 |
| Close above $66.65 on volume ≥15M with MACD histogram re-expanding | Re-enter/re-add on breakout |
| Breakdown below $58.20 | Stop out of retained core |
MDLZ's 2025 earnings collapse is a cyclical trough driven by cocoa prices, not structural deterioration, creating a mispriced opportunity with 75% earnings recovery already consensus while the stock trades at a discount to peers at 18.6x forward P/E.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $62.23 | bullish |
| 50 SMA | $60.87 | bullish |
| 200 SMA | $57.83 | bullish |
| MACD | +0.67 | bullish |
| MACD Signal | +0.54 | bullish |
| MACD Histogram | +0.13 | neutral |
| RSI (14) | 55.6 | neutral |
| Bollinger Upper Band | $64.46 | neutral |
| Bollinger Middle Band | $61.33 | neutral |
| Bollinger Lower Band | $58.21 | neutral |
| ATR (14) | $1.69 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Trim 30% of MDLZ at $62.50; retain core defensive position with stops at $58.20
Trim ~30% of MDLZ exposure at $62.50 (lower end of 30-50% range) to capture tactical risk (unfavorable entry, cooling momentum, recovery priced in at 18.6x requiring five positive outcomes) without abandoning the defensive sleeve. MACD histogram decayed 72% in eight sessions and volume collapsed from 20M to 5M support reduction. However, bullish MA stack intact, MACD line still positive at 0.67, and recovery dynamics remain constructive for core position. Stop on retained core at $58.20. Re-entry at $58.20 on confirmed support with MACD expansion or above $66.65 on volume ≥15M with MACD histogram re-expanding offers better asymmetry than current $62.50 level.
When: Close above $66.65 with volume ≥15M and MACD histogram re-expanding
Then: Re-engage/add to position
Cocoa normalization provides multi-quarter operating income tailwind not yet in numbers
↩ rebuts: “Bear flagged cocoa cost volatility as a risk without recognizing it as a catalyst”
· concedes: Net Debt/EBITDA at 3.8x is elevated (though solves itself with EBITDA recovery); 2026 H2 hedge roll-offs needed to unlock margin recovery mechanically; No near-term re-rating catalyst identified; Current entry not at bottom of range - stock already 23% off January 2026 low of $50.64
MDLZ already prices in the consensus 2026 recovery; any disappointment on cocoa normalization, EM volume, or GLP-1 headwinds triggers multiple compression from 18.6x toward 14-15x, driving the stock to $50-55 with asymmetric downside risk that makes current levels a trap, not a setup.
· concedes: MDLZ is a high-quality defensive compounder; Cocoa prices did decline from spike levels; Investment grade credit rating maintained (though with negative outlook risk); Sentiment is not extremely bearish (5.3/10, not 1-2)
→ vs conservative: Beta 0.40 and 3.19% dividend yield provide false security — low-beta names in structural decline underperform high-beta names with momentum because the latter can recover on volatility alone; 3.19% yield evaporates in three weeks if price drops 8%
→ vs conservative: Net debt to EBITDA normalization to 2.5x requires IF recovery — circular reasoning where bull case is financing the bull case; buybacks executed at high end of historical range during EBITDA trough created the leverage problem
→ vs conservative: Sentiment data showing low retail/community engagement is not neutral — absence of retail positioning means institutional flow (more sensitive to multiple compression and macro rates) sets the marginal price
→ vs neutral: 'Wait for confirmation' technical advice is actually the riskier trade because MDLZ confirmation tends to come AFTER the move, not before — when stock breaks 50 SMA at $60.87 on volume, investor will be chasing lower or sitting on 5% loss
→ vs neutral: Technical picture is not 'constructive but cooling' — MACD histogram decaying 72%, RSI bearish divergence, price $1.74 above rising 50 SMA moving into overhead supply signals coiled spring with direction already telegraphed by momentum failure
Support: 61.33 · 60.87 · 58.21 · 57.83 | Resistance: 63.08 · 64.46 · 66.65
MDLZ is in a constructive but cooling technical setup with a clean bullish MA stack (price > 10 EMA > 50 SMA > 200 SMA) and price ~$1.74 above the 50 SMA. Momentum is decelerating (MACD histogram halved from +0.47 to +0.13) and RSI shows mild bearish divergence vs. the July 29 spike high. The stock is consolidating below the Bollinger Upper Band ($64.46) with low volume (5.04M vs. 20.22M on the breakout), suggesting neither aggressive buying nor breakdown conviction. Key supports: $60.87 (50 SMA), $58.21 (Bollinger lower); key resistance: $64.46 (Bollinger upper). Recommendation: HOLD — await either a pullback to the 50 SMA or a confirmed breakout above $64.46 on expanding volume.
Market Cap
$79.9B
P/E (TTM)
38.18
Forward P/E
18.63
PEG Ratio
1.04
Price/Book
3.01
EV/EBITDA (TTM)
~13.1x
Dividend Yield
3.19%
Beta
0.40
52-Week High
$66.65
52-Week Low
$51.20
Current Price (proxy)
~$62.00
EPS (TTM)
$1.64
Forward EPS
$3.36
FCF (TTM)
$2.25B
Revenue (2025)
38,537
Cost of Revenue (2025)
27,602
Gross Profit (2025)
10,935
Gross Margin % (2025)
28.4%
Operating Income (2025)
3,548
Operating Margin % (2025)
9.2%
Net Income (2025)
2,451
Diluted EPS (2025)
$1.89
EBITDA (2025)
4,971
Interest Expense (2025)
599
Cash & Equivalents (2025)
2,125
Inventory (2025)
4,419
Total Current Assets (2025)
12,951
Goodwill (2025)
24,336
Intangibles (2025)
19,628
PP&E Net (2025)
11,398
Total Assets (2025)
71,487
Total Debt (2025)
21,804
Net Debt (2025)
19,080
Stockholders' Equity (2025)
25,838
D/E Ratio (2025)
0.84x
Current Ratio (2025)
0.59
OCF (2025)
4,514
CapEx (2025)
1,279
FCF (2025)
3,235
Dividends Paid (2025)
2,487
Buybacks (2025)
2,385
ROE (2025)
13.3%
ROA (2025)
4.1%
Net Margin (2025)
6.4%
Net Debt/EBITDA
3.8x
Interest Coverage
4.6x
FCF Yield
~4.0%
Revenue CAGR 3Y
+7.0%
Forward EPS Growth
+105%
Strengths
Concerns
MDLZ is a high-quality defensive compounder currently in a cyclical earnings trough driven by commodity input costs (cocoa, sugar, dairy), with 2025 net income collapsing 47% YoY to $2.45B as gross margins compressed by ~10.7 percentage points. The market has largely priced this in with forward P/E of 18.6x, and analyst consensus expects a sharp ~75% earnings rebound in 2026 as cocoa prices normalize from 2024 peaks. With a defensible global brand portfolio (Oreo, Cadbury, etc.), 3.19% growing dividend, ~4% FCF yield, and extremely low beta (0.40), MDLZ is positioned as a classic late-cycle defensive holding attractive for income-oriented portfolios, though primary risks include delayed commodity normalization or credit-rating pressure from elevated leverage.